Aethlon Medical, Inc.
(NASDAQ : AEMD)

( )
AEMD After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
INOInovio Pharmaceuticals, Inc. 9.58%25.6210.1%$1546.60m
TMOThermo Fisher Scientific, Inc. -0.94%378.971.0%$538.57m
MDTMedtronic Plc 2.24%92.840.6%$521.35m
DXCMDexCom, Inc. -8.05%404.238.2%$486.35m
BDXBecton, Dickinson & Co. 0.02%257.421.0%$481.90m
ABTAbbott Laboratories 0.11%93.140.8%$476.75m
DHRDanaher Corp. -0.61%182.550.7%$427.54m
BSXBoston Scientific Corp. -0.72%34.431.0%$413.53m
QDELQuidel Corp. -4.92%234.517.7%$393.18m
ISRGIntuitive Surgical, Inc. -0.80%571.292.4%$318.77m
SYKStryker Corp. 0.01%177.911.3%$300.75m
BAXBaxter International, Inc. -2.11%83.431.8%$259.35m
ZBHZimmer Biomet Holdings, Inc. 1.28%120.961.7%$204.24m
ALGNAlign Technology, Inc. -1.12%270.246.3%$202.75m
BIOBio-Rad Laboratories, Inc. -1.98%468.222.9%$199.19m

Company Profile

Aethlon Medical, Inc. is a therapeutic technology company, which focuses on addressing global health and biodefense needs. It develops Aethlon Hemopurifier, a medical device that targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The firm operates through two segments: Aethlon and ESI. The Aethlon segment involves in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in May 1998 and is headquartered in San Diego, CA.